The study by Madison et al. found Wnt3a expressed in 89.9% of CRC cases (weak in44.7% and strong in 45.2%), and a relationship between positivity for Wnt3a with thepresence of vasculogenic mimicry. Here, WNT3A is linked to colorectal carcinoma.